Scisparc (SPRC) Peer Comparison
$6.58
$-0.04
(-0.60%)
As on 28-Aug-2026 16:00EDT
Market cap
$4 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
0.1
P/B Ratio
0.9
Div. Yield
0 %
Edit
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
4 | 475 | 171 | 104 | 3 |
Revenue ($ Mln) |
1 | 192 | 12 | -- | 0 |
Net Profit ($ Mln) |
-12.18 | 22.25 | -20.18 | -31.50 | -4.84 |
Net Margin (%) |
-- | 11.60 | -170.10 | -- | -- |
RoE (%) |
-196.55 | 8.26 | -50.91 | -385.07 | -93.33 |
Price to Earnings |
0.07 | 21.68 | -- | -- | -- |
Price-To-Book |
0.91 | 1.76 | 4.77 | 19.23 | 0.36 |
Cashflow ($ Mln)
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-4.14 | 27.59 | -14.53 | -27.88 | -3.96 |
|
Cash Flow from Investing Activities
|
-1.40 | -10.65 | -19.54 | -- | -0.98 |
|
Cash from Financing Activities
|
8.59 | -19.86 | 29.62 | 25.37 | 3.82 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-190.22 | 7.33 | -53.14 | -219.95 | -92.74 |
|
ROE (%)
|
-196.55 | 7.64 | -63.86 | -366.29 | -93.33 |
|
ROA (%)
|
-135.56 | 5.38 | -29.90 | -143.79 | -58.56 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-1,422.78 | 11.19 | -140.80 | -- | -28,458.82 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.34 | 0.12 | -0.16 | -- | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-93.81 | 39.66 | 20.99 | -17.73 | 66.84 |
|
EPS Growth (%)
|
-6.54 | 0.23 | 0.34 | 0.57 | 0.97 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-0.01 | 21.55 | -9.91 | -2.62 | -0.09 |
|
Price / Book Value
|
0.02 | 1.62 | 5.43 | 8.14 | 0.05 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.34 | 9.46 | -8.93 | -2.49 | 1.13 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.09 | 0.04 | 0.19 | 0.25 | 0.00 |
|
Short term debt to equity ratio
|
0.09 | 0.01 | 0.01 | 0.20 | 0.00 |
|
Current Ratio
|
2.41 | 4.07 | 2.33 | 1.97 | 1.78 |
|
Quick Ratio
|
2.38 | 2.28 | 2.17 | 1.82 | -- |
|
Interest Coverage
|
-1,141.18 | 28.16 | -35.19 | -48.87 | -498.70 |
Operating Efficiency Ratios
| Scisparc (SPRC) | Kamada - ADR | MediWound - ADR | PolyPid (PYPD) | Painreform (PRFX) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
77.34 | 16.10 | 13.99 | -- | 835.29 |
|
Asset Turnover
|
0.10 | 0.48 | 0.21 | 0.00 | 0.00 |
|
Receivable days
|
1,200.08 | 52.87 | 88.56 | -- | 2,803.83 |
|
Inventory Days
|
152.59 | 287.45 | 90.41 | -- | -- |
|
Payable days
|
1,297.86 | 89.48 | 102.65 | -- | 110.14 |
|
Cash Conversion Cycle
|
54.81 | 250.84 | 76.33 | -- | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
